- Patent Title: Treatment of psychiatric conditions such as resistant depression, bipolar disorder and/or major depressive disorder via application of repetitive transcranial magnetic stimulation with thyroid hormone treatment and/or quetiapine
-
Application No.: US16769895Application Date: 2018-12-14
-
Publication No.: US11638831B2Publication Date: 2023-05-02
- Inventor: Antonios Zamar
- Applicant: THE LONDON PSYCHIATRY CENTRE
- Applicant Address: GB London
- Assignee: THE LONDON PSYCHIATRY CENTRE
- Current Assignee: THE LONDON PSYCHIATRY CENTRE
- Current Assignee Address: GB London
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB1720816 20171214,GB1819647 20181201
- International Application: PCT/GB2018/053634 WO 20181214
- International Announcement: WO2019/116048 WO 20190620
- Main IPC: A61P25/24
- IPC: A61P25/24 ; A61N2/00 ; A61B5/0245 ; A61B5/00 ; A61K31/198 ; A61K31/554 ; A61N2/02 ; C12Q1/6883 ; G01N33/78

Abstract:
The present invention relates to treatment of a psychiatric condition, for example resistant depression (RD), bipolar disorder (either threshold or sub-threshold) and/or major depressive disorder via application of repetitive transcranial magnetic stimulation with a drug treatment, in particular application of repetitive transcranial magnetic stimulation with treatment to modulate the activity of the neurones and induce neuroplasticity and the use of Thyroid hormone treatment to increase quantity or activity of thyroid hormones, for example for treatment of thyroid dysfunction. Patients may be selected for treatment by testing for the presence of normal thyroid function.
Information query